Showing results (471-480 of 7,296) with videos related to
Sort By:
Pageof 730
Cell Cycle (Georgetown, Tex.)|May 20, 2017
Several inhibitors of the Plk1 Polo-Box Domain turn out to be non-specific protein alkylatorsVincent Archambault, Karine NormandinCell Cycle (Georgetown, Tex.)|May 10, 2017
The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxiaJun Zhang, Lanlan Zhou, Shuai Zhao, et al.Cell Cycle (Georgetown, Tex.)|April 5, 2018
Targeting HAUSP in both p53 wildtype and p53-mutant tumorsOmid Tavana, Hongbin Sun, Wei GuCell Cycle (Georgetown, Tex.)|April 7, 2018
Degraded melanocores are incompetent to protect epidermal keratinocytes against UV damageWen-Juan Yi, Meng-Yun Su, Ying Shi, et al.Cell Cycle (Georgetown, Tex.)|April 24, 2018
Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesisYang Yang, Yanzhe Gao, Anastasia Zlatanou, et al.Cell Cycle (Georgetown, Tex.)|September 1, 2016
Why is an energy metabolic defect the common outcome in BMFS?Paolo Degan, Silvia Ravera, Enrico CappelliCell Cycle (Georgetown, Tex.)|September 1, 2016
Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor/S100 interactionsDavid H Lee, Bethany K Asare, Rajendram V RajnarayananCell Cycle (Georgetown, Tex.)|September 22, 2016
Coronin 1B supports RhoA signaling at cell-cell junctions through Myosin IIRashmi Priya, Kenneth Wee, Srikanth Budnar, et al.Cell Cycle (Georgetown, Tex.)|March 18, 2010
An RNA end tied to the cell cycle: new ties to apoptosis and microRNA formation?Zbigniew DominskiCell Cycle (Georgetown, Tex.)|March 18, 2010
Mutation at Ser392 specifically sensitizes mutant p53H175 to mdm2-mediated degradationSébastien Gillotin, Damian Yap, Xin LuPageof 730